Results 171 to 180 of about 136,614 (358)

Landscape of Somatic and Age‐Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long‐Read Sequencing

open access: yesMedComm, Volume 7, Issue 1, January 2026.
This study leveraged long‐read sequencing (LRS) to provide a comprehensive analysis of structural variations (SVs) in the human hepatocellular carcinoma (HCC) genome. Somatic SVs were found to be more prevalent in HBV‐related HCC, with chromosome 1 emerging as the primary hotspot for these alterations. Notably, HBV‐related HCC exhibited a significantly
Zhewen Wei   +24 more
wiley   +1 more source

Assessment of Occupational Exposure to Blood and Other Body Fluids Among Healthcare Workers in a South‐Western Chinese Tertiary Hospital From 2018 to 2023: A Descriptive Cross‐Sectional Study

open access: yesNursing Open, Volume 13, Issue 1, January 2026.
ABSTRACT Aim Healthcare workers face significant occupational exposure risks from biological and non‐biological hazards, with needlestick injuries being the most common hazard. This study aimed to assess the extent of occupational exposure among various healthcare workers. Design A descriptive cross‐sectional study.
Lulin Chen   +6 more
wiley   +1 more source

Preliminary assessment of various additives on the specific reactivity of anti- rHBsAg monoclonal antibodies [PDF]

open access: yes, 2015
Background: Antibodies have a wide application in diagnosis and treatment. In order to maintain optimal stability of various functional parts of antibodies such as antigen binding sites, several approaches have been suggested.
Mohammadi, S.   +3 more
core  

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

open access: yesSmall Methods, Volume 10, Issue 2, 22 January 2026.
The review presents a comprehensive overview of each component of lipid nanoparticles(LNPs)and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu   +6 more
wiley   +1 more source

Low hepatitis B surface antigen at baseline and increased ALT levels during treatment predicts significant HBsAg decline in peginterferon alfa added to long-term nucleus(t)ice analogue. Results from two randomized controlled trials in 165 patients

open access: bronze, 2020
Mina Farag   +13 more
openalex   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 1, Page 132-144, January 2026.
In East Asian patients with chronic hepatitis B, rates of virologic suppression through 5 years were high in those treated continuously with tenofovir alafenamide (TAF) and in those switched from tenofovir disoproxil fumarate (TDF) to TAF. Improved renal and bone safety was observed in patients switching from TDF to TAF.
Grace Lai‐Hung Wong   +15 more
wiley   +1 more source

Long‐Term Follow‐Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 2, Page 231-241, January 2026.
We evaluated long‐term outcomes following nucleos(t)ide analogue discontinuation in HBeAg‐negative chronic hepatitis B. HBsAg loss was infrequent. Early HBsAg loss occurred in patients with low end‐of‐treatment HBsAg levels and without ALT flare, whilst late HBsAg loss typically followed ALT flares and was associated with higher end‐of‐treatment HBsAg ...
Simon J. Hume   +18 more
wiley   +1 more source

A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients [PDF]

open access: gold, 2023
Kaimin Song   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy